September 28, 2026

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with 18.73% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to capture investor attention with its expansive portfolio and robust market presence. With a market..

Haleon plc (HLN) Investor Outlook: Analyzing a 28.88% Potential Upside in the Healthcare Sector

Haleon plc (HLN) is capturing the attention of investors with a compelling potential upside of 28.88%, as projected by analysts. This United Kingdom-based healthcare giant, with..

BioNTech SE (BNTX) Stock Analysis: Navigating a 19% Upside Amidst Revenue Challenges

As investors continue to navigate the volatile landscape of biotechnology stocks, BioNTech SE (NASDAQ: BNTX) presents both challenges and opportunities. Headquartered in Mainz, Germany, BioNTech has..

Waters Corporation (WAT) Stock Analysis: Strong Buy Consensus with Promising Growth Potential

Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector’s Diagnostics & Research industry, is capturing investor attention with its robust market position and promising..

Dr. Reddy’s Laboratories (RDY) Stock Analysis: Potential Upside with Strategic Global Footprint

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a heavyweight in the healthcare sector, continues to capture investor attention with its global operations in the competitive landscape of..

Molina Healthcare Inc (MOH) Stock Analysis: Investor Outlook Amid a 9.57% Potential Upside

Molina Healthcare Inc. (NYSE: MOH) presents an intriguing opportunity for investors looking at the healthcare sector, particularly within the realm of healthcare plans. Headquartered in Long..

Royalty Pharma plc (RPRX) Stock Analysis: Unlocking a Potential 11.88% Upside

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector with a compelling business model centered on acquiring biopharmaceutical royalties and funding innovation. With a..

Genmab A/S (GMAB) Stock Analysis: Strong Buy Ratings and 10.81% Upside Potential

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, continues to captivate investor interest with its promising pipeline and strategic collaborations. Headquartered in Copenhagen,..

Medtronic plc (MDT) Stock Analysis: Valuation Insights and a Potential 18% Upside

Medtronic plc (MDT), a leader in the healthcare sector, is making waves among investors with its robust performance and promising outlook. Headquartered in Galway, Ireland, Medtronic..

Biogen Inc. (BIIB) Stock Analysis: Assessing Growth Potential with a 4.65% Upside

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, primarily operates within the drug manufacturing industry. With a market capitalization of $33.63 billion, Biogen is..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings and 12% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a venerable name in the healthcare sector, commands attention with its substantial market presence and robust product portfolio. Based in..

Insulet Corporation (PODD) Stock Analysis: Exploring a 26% Potential Upside in the Healthcare Sector

Insulet Corporation (NASDAQ: PODD) is a prominent player in the healthcare sector, specifically within the medical devices industry, with a focus on innovative insulin delivery systems...

Amgen Inc. (AMGN) Stock Analysis: Navigating a Competitive Market with Strong Returns

For investors seeking exposure in the healthcare sector, Amgen Inc. (NASDAQ: AMGN) presents a compelling opportunity. As a leading player in the drug manufacturing industry, Amgen’s..

IQVIA Holdings (IQV) Stock Analysis: A Healthcare Giant with a 3.4% Upside Potential and Strong Buy Ratings

IQVIA Holdings, Inc. (NYSE: IQV) stands as a titan in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $44.5 billion, IQVIA..

Becton, Dickinson and Company (BDX) Stock Analysis: Potential Upside and Steady Growth Make It a Compelling Buy

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, commands attention from investors with its robust market presence and potential upside. With a..

Baxter International Inc. (BAX) Stock Analysis: Evaluating Growth Potential and Analyst Consensus

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, stands at a critical juncture for investors eyeing opportunities within the medical instruments and supplies..

The Cooper Companies, Inc. (COO) Stock Analysis: Exploring a 19.56% Potential Upside for Investors

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, presents an intriguing opportunity for..

Natera, Inc. (NTRA) Stock Analysis: Navigating High Growth and Investor Sentiment in the Healthcare Sector

Investors eyeing the healthcare sector may want to pay close attention to Natera, Inc. (NASDAQ: NTRA), a prominent player in the diagnostics and research industry. With..

UnitedHealth Group (UNH) Stock Analysis: An Investor’s Perspective on Its 27.92% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, commands a formidable market capitalization of $338.03 billion. As a leader in the healthcare plans..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Attractive 24.65% Upside Potential

GE HealthCare Technologies Inc. (GEHC) is establishing itself as a key player within the healthcare sector, specifically in the medical devices industry. With a market capitalization..

Search

Funds

September 28, 2026

Search

Funds

September 28, 2026

FTSE 100

Funds